"Alemtuzumab Slows Brain Volume Loss Over 4 Years Despite Most Relapsing-Remitting Multiple Sclerosis Patients Not Receiving Treatment for 3 Years (P7.263)." Neurology
84.14 Supplement
(2015):
P7.263.
Web. 01 Dec. 2023.
Advertisement